4 reports

THIS IS LIKELY TO HAVE A SIGNIFICANT IMPACT ON BOTH THE DESIGNING AND DELIVERY OF DIGITAL HEALTHCARE SOLUTIONS.

  • Endocrine Disease
  • World
  • Forecast
  • Market Size
  • VOLUNTIS

ESYSTA FROM EMPERRA E-HEALTH TECHNOLOGIES IS ANOTHER ONE OF THE HIGHEST-RANKING DEVICES IN THIS SEGMENT.

  • Endocrine Disease
  • Respiratory Disease
  • World
  • Forecast
  • Adherium Limited

One unit refers to one disposable insulin pen.

  • Clinical Trial
  • Endocrine Disease
  • Insulin Delivery
  • Pharmaceutical
  • Sanofi S.A.

WITH ONE FULL YEAR OF SERVICE AS OF JANUARY ##, 2018.

  • Endocrine Disease
  • Healthcare
  • Patient Monitoring
  • United States
  • Company